Joint practical guideline of the Hungarian Pain Society Chronic Headache Working Group and the Hungarian Headache Society on the use of calcitonin gene-related peptide (CGRP)-targeting therapies in migraine
Abstract
INTRODUCTION: Inhibition of the calcitonin gene-related peptide (CGRP) pathway offers a novel therapeutic option in the prevention of migraine attacks.
OBJECTIVE: The aim of this guideline is to provide practical recommendations for the safe, effective, and personalized use of CGRP inhibitors in episodic and chronic migraine within Hungarian clinical practice.
METHOD: The recommendations were developed based on international guidelines and current clinical trial evidence. The guideline takes into account drug efficacy, side-effect profiles, contraindications, as well as considerations for specific patient populations.
RESULTS AND RECOMMENDATIONS: CGRP antagonists - including monoclonal antibodies and gepants - may be applied even as first-line acute or preventive treatments owing to their efficacy and favorable safety profiles, particularly when the patient's clinical status, preferences, or comorbidities justify their use. Adverse events are mostly mild, and overall safety is favorable. Therapeutic decisions should be followed by a three-month evaluation period, and in the case of insufficient response, drug switching or combination therapy should be considered.
CONCLUSION: According to international evidence, a structured therapeutic algorithm and a patient-tailored approach may have a beneficial effect and are expected to contribute to improved quality of life in patients with migraine. Orv Hetil. 2025; 166(50): 1963-1974.
Bevezetés: A kalcitoningénnel kapcsolatos peptid…
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.